Foda BM, Misek SA, Gallo KA, Neubig RR. Inhibition of the Rho/MRTF pathway improves the response of BRAF-resistant melanoma to PD1/PDL1 blockade. International journal of cancer. 2024. doi:10.1002/ijc.35056
O’Hare P, Cooney T, de Blank P, et al. Resistance, rebound, and recurrence regrowth patterns in pediatric low-grade glioma treated by MAPK inhibition: A modified Delphi approach to build international consensus-based definitions-International Pediatric Low-Grade Glioma Coalition. Neuro-oncology. 2024. doi:10.1093/neuonc/noae074
Iorgulescu B, Ruthen N, Ahn R, et al. Antigen presentation deficiency, mesenchymal differentiation, and resistance to immunotherapy in the murine syngeneic CT2A tumor model. Frontiers in immunology. 2023;14:1297932. doi:10.3389/fimmu.2023.1297932
Arwood ML, Liu Y, Harkins SK, et al. New scaffolds for type II JAK2 inhibitors overcome the acquired G993A resistance mutation. Cell chemical biology. 2023. doi:10.1016/j.chembiol.2023.05.007